According to recent research carried out by Macmillan Cancer Support, the number of people in the UK who have cancer will reach a record high of 2.5 million in 2015, up 400,000 from five years ago. Around 40% of these people will receive treatment in the form of radiotherapy.
e2v is widely known for its involvement in space technology, most recently with the Rosetta Space Mission, which successfully landed on a comet in November 2014. However, e2v is also heavily involved in the medical market, with over 90% of all radiotherapy machines across the globe containing e2v’s technology. In fact, every two minutes someone in the world receives cancer treatment using technology built at e2v’s facility in Chelmsford. With over 65 years of research and development in this field, e2v is one of the leaders in the fight against cancer, helping to develop innovative ways to treat and cure people suffering from this vicious disease.
Today, 4th February, marks World Cancer Day and to show support in raising awareness of the treatment and work carried out by people across the globe, e2v held a special event at its Chelmsford facilities. Over 30 guests attended, including the Mayor of Chelmsford, the Chairman and Leader of Essex County Council, the Leader of Chelmsford City Council, 16 ward councillors, a radiographer and a doctor from Colchester Hospital and representatives from local charities.
The day’s activities included presentations from employees on the benefits of e2v’s technology in the fight against cancer and tours of e2v’s facilities, where guests were given the opportunity to see e2v products being made and to talk to the people who make them. There was also a presentation by a hospital engineer from Amsterdam, whose hospital in the Netherlands uses e2v’s products to help treat patients and save lives. Macmillan volunteer Liam DeRoe also spoke about how the Macmillan charity supports patients on a daily basis.
Ewan Livingstone, President of e2v’s RF Power Medical business unit commented, “The customer is at the heart of everything that we do here at e2v and producing innovative products for the fight against cancer is something that we are privileged to be involved in. Today we wanted to bring together people from across the field of cancer treatment – engineers, medical staff, care workers and charities – to show how we are all working together to help rid us of this vicious disease. Along the way we aim to bring hope to those affected either directly or indirectly by cancer, and show that the fight against cancer is not beyond us!”
Comments from distinguished guests are available upon request.
For more information about e2v visit www.e2v.com
– Ends –
Media Contact: For enquiries about this press release contact: Jennifer Spencer-Charles; Jennifer.Spencer-Charles@e2v.com
Notes to Editor:
About e2v: e2v is a leading global provider of specialist technology for high performance systems and equipment; delivering solutions, sub-systems and components for applications within medical & science, aerospace & defence, and commercial & industrial markets. e2v employs approximately 1750 people, has design and operational facilities across Europe, North America and Asia, and has a global network of sales and technical support offices. e2v has annual sales of GBP220m and is listed on the London Stock Exchange.
For e2v media enquiries contact:
Press office: +44 (0)1245 453625
Mobile: +44 (0)7803 150945